ABPI response to Innovation Strategy

The government has published a new Innovation Strategy, which sets out plans to cement the UK’s position as a world leader in science and research. 

Our sector invests more in UK research and development than any other, so it’s great to see today’s Innovation Strategy include a focus on cutting-edge technologies like genomics, which have huge potential to help patients, create jobs and boost the economy. Richard Torbett, Chief Executive, ABPI

In response, ABPI Chief Executive Richard Torbett said: 

“If we are to meet the ambition for the UK to be a science superpower we have to unlock the potential - and support the growth - of the most innovative sectors, including life sciences.

"Our sector invests more in UK research and development than any other, so it’s great to see today’s Innovation Strategy include a focus on cutting-edge technologies like genomics, which have huge potential to help patients, create jobs and boost the economy.

“Combined with the recent life sciences vision, this strategy sets out an exciting road ahead.”

TAGS
  • Innovation

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.